Cancer Communications
indexed by SCI
BMC

Important notice

 

 

We would like to inform you that Chinese Journal of Cancer has changed the title to Cancer Communications on 1st March 2018.
Cancer Communications is published by Wiley from 1 January 2020. The journal website is available at: https://onlinelibrary.wiley.com/journal/25233548

 

 

Cancer Communications (CJC) 获评“2019中国最具国际影响力学术期刊”


In pursuit of a flawless aphrodite: paving the way to scarless oncoplastic breast surgery
Liling Zhu, Shunrong Li, Luyuan Tan, Xiaolan Zhang, Jiannan Wu, Fengxi Su, Kai Chen & Erwei Song
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 12/4/2019   doi:10.1186/s40880-019-0422-4
Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis
Jun-Hai Tang, Lin Yang, Ju-Xiang Chen, Qing-Rui Li, Li-Rong Zhu, Qing-Fu Xu, Guo-Hao Huang, Zuo-Xin Zhang, Yan Xiang, Lei Du, Zheng Zhou & Sheng-Qing Lv
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 12/3/2019   doi:10.1186/s40880-019-0424-2
A nomogram for individualized estimation of survival among adult patients with adrenocortical carcinoma after surgery: a retrospective analysis and multicenter validation study
Jianqiu Kong, Junjiong Zheng, Jinhua Cai, Shaoxu Wu, Xiayao Diao, Weibin Xie, Xiong Chen, Chenyi Liao, Hao Yu, Xinxiang Fan, Chaowen Huang, Zhuowei Liu, Wei Chen, Qiang Lv, Haide Qin, Jian Huang & Tianxin Lin
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 11/27/2019   doi:10.1186/s40880-019-0426-0
The immune landscape of esophageal cancer
Tu-Xiong Huang, Li Fu
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 11/26/2019   doi:10.1186/s40880-019-0427-z
Long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non-small cell lung cancer
Hideharu Kimura, Tomoyuki Araya, Taro Yoneda, Hiroki Shirasaki, Koji Kurokawa, Tamami Sakai, Hayato Koba, Yuichi Tambo, Shingo Nishikawa, Takashi Sone & Kazuo Kasahara
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 11/21/2019   doi:10.1186/s40880-019-0423-3
Post-translational modification of Parkin and its research progress in cancer
Dan Ding, Xiang Ao, Ying Liu, Yuan-Yong Wang, Hong-Ge Fa, Meng-Yu Wang, Yu-Qi He & Jian-Xun Wang
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 11/21/2019   doi:10.1186/s40880-019-0421-5
Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer
Xiangyu Zhang
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 11/21/2019   doi:10.1186/s40880-019-0425-1
Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage I nasopharyngeal carcinoma
You-Ping Liu, Xing Lv, Xiong Zou, Yi-Jun Hua, Rui You, Qi Yang, Le Xia, Shao-Yan Guo, Wen Hu, Meng-Xia Zhang, Si-Yuan Chen, Mei Lin, Yu-Long Xie, Li-Zhi Liu, Rui Sun, Pei-Yu Huang, Wei Fan, Xiang Guo, Ming-Huang Hong & Ming-Yuan Chen
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 11/15/2019   doi:10.1186/s40880-019-0415-3
Tumor mutational burden as a new biomarker for PD-1 antibody treatment in gastric cancer
Gunnar Folprecht
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 11/14/2019   doi:10.1186/s40880-019-0417-1
Neoadjuvant stereotactic radiosurgery for intracerebral metastases of solid tumors (NepoMUC): a phase I dose escalation trial
hristian D. Diehl, Ehab Shiban, Christoph Straube, Jens Gempt, Jan J. Wilkens, Markus Oechsner, Carmen Kessel, Claus Zimmer, Benedict Wiestler, Bernhard Meyer & Stephanie E. Combs
[ Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 11/9/2019   doi:10.1186/s40880-019-0416-2

more papers...






Gastric cancer  

 

Edited by Yun Dai and Li Yan
 

This thematic series discusses the molecular classifications of gastric cancer by the Cancer Genome Atlas (TCGA) and the Asian Cancer Research Group (ACRG) as well as the implications in personalized therapeutic choices; discusses the evolution of gastric surgery and presents perspectives on surgical techniques in treating gastric cancer; and reviews current and emerging targeted agents as well as immunotherapies in treating gastric cancer. With these advancements in molecular characterization, surgical intervention, and targeted and immunotherapies, gastric cancer will enter a personalized medicine era in the next 5 years.

 

Read thematic series > 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 

Tumor angiogenesis  

 

Edited by Francesco Pezzella
and Chao-Nan Qian 

Forming efficient vasculature network, also known as tumor angiogenesis, is a critical hallmark in tumor development. Explorations on its underlying molecular mechanisms have resulted in several novel anti-cancer drugs. However, the modest survival benefits from anti-angiogenic therapy have forced us to revisit our understanding on tumor angiogenesis. In this special issue, world-leading experts have contributed their critical thoughts to reveal alternative tumor angiogenesis approaches and potential treatment targets.

 

Read thematic series > 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 

Lung cancer 


 

Edited by Lin Yan and Wei Zhang  

 

Lung cancer accounts for approximately 21% of worldwide cancer deaths and a staggering 1.6 million new cases are diagnosed every year. In China, lung cancer has become a particularly challenging disease because of air pollution and smoking. This thematic series discusses the proper use of targeted agents in treating lung cancer, reviews the application of biomarkers in clinical management and drug development, and analyzes the unique challenges in developing novel drugs for lung cancer in China.

 

Read thematic series > 



CJC Wechat 微信公众号


 

Editorial Manager


CC adopts ScholarOne Manuscripts to manage its submissions from Nov.1, 2019

 Submission Guidelines  

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CC is now published by Wiley

© Cancer Communications

651 Dongfeng Road East,Guangzhou 510060, P.R.China